T lymphocytes promote calreticulin exposure, HMGB1 and IL-1β release, leading to DC uptake and cross presentation, providing a mechanism for amplification and self-perpetuation of the immune response against cancer neoantigens (100, 101). Here, IL1B is linked to cancer.